Physician profile
Nicholas Baker
NPI 1568624393
$137,893.52
in general payments reported to CMS, 2019-2025
18 companies · $40K in 2025
The $40K reported for 2025 was more than what 96% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,328 · 2020: $24.86 · 2021: $174 · 2022: $2,510 · 2023: $8,350 · 2024: $85K · 2025: $40K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $64K · Education: $32K · Travel and Lodging: $17K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Food and Beverage: $5,411 · Grant: $5,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $63,947.50 |
| Education | $32,147.33 |
| Travel and Lodging | $17,350.79 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,000.00 |
| Food and Beverage | $5,410.94 |
| Grant | $5,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| On Target Laboratories, INC | $68,644.94 | 2024-2025 | Cytalux |
| Ethicon INC. | $15,824.06 | 2019-2025 | Monarch Platform |
| Stryker Corporation | $15,014.41 | 2023-2024 | 1788, Iconix, 1688 |
| Medical Device Business Services, INC. | $14,167.91 | 2019-2024 | Monarch, Echelon Flex |
| Arthrex, INC. | $9,507.97 | 2025 | |
| Noah Medical Corporation | $6,517.08 | 2023-2024 | Galaxy |
| Intuitive Surgical, INC. | $5,527.14 | 2019-2025 | Da Vinci Surgical System |
| Zimmer Biomet Holdings, INC. | $1,344.76 | 2022 | |
| Medtronic, INC. | $435.84 | 2022-2024 | Endo Gia Ultra, Signia |
| Davol INC. | $400.05 | 2019-2024 | Progel Applicator Spray Tips |
| Galvanize Therapeutics, INC | $160.00 | 2022 | |
| Ethicon US, LLC | $103.81 | 2023-2024 | Harmonic, Surgicel Nu-Knit |
| Atricure, INC. | $85.43 | 2023-2024 | |
| Ethicon Endo-Surgery INC. | $64.34 | 2024 | Echelon; Endopath, Linx Reflux Management System |
| W. L. Gore & Associates, INC. | $36.85 | 2024 | Gore Synecor Biomaterial |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $31.34 | 2024 | Dupixent |
| Pulmonx Corporation | $27.59 | 2024 | Zephyr Delivery Catheter, Chartis Catheter, Zephyr Endobronchial Valve |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$172,160.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.